|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Basic and Pharmaceutical Sciences, Albany College of Pharmacy, Albany, New York, United States
2 Zentiva a.s., Prague, Czech Republic
3 Dept. of Physiology & Biophysics, University of Tennessee, Memphis, Memphis, Tennessee, United States
* To whom correspondence should be addressed. E-mail: blatteis{at}physio1.utmem.edu.
Norepinephrine (NE) microdialyzed into the preoptic area (POA) raises core temperature (Tc) via
1-adrenoceptors (AR), quickly and independently of POA prostaglandin (PG)E2, and
2-AR, after a delay and PGE2-dependently. Since systemic lipopolysaccharide (LPS) activates the central noradrenergic system, we investigated whether preoptic NE mediates LPS fever. We injected LPS (2 µg/kg iv) into guinea pigs prepared with intraPOA microdialysis probes and determined POA cerebrospinal (CSF) NE levels. We similarly microdialyzed prazosin (
1 blocker, 1 µg/µl), yohimbine (
2 blocker, 1 µg/µl), SC-560 (cyclooxygenase [COX]-1 blocker, 5 µg/µl), acetaminophen (presumptive COX-1v blocker, 5 µg/µl), or MK-0663 (COX-2 blocker, 0.5 µg/µl) into other animals before iv LPS and measured CSF PGE2. All the agents were perfused at 2 µg/min for 6 h. Tc was monitored constantly. POA NE peaked within 30 min after LPS, then returned to baseline over the next 90 min. Tc increased within 12 min to a first peak at ~60 min and to a second at ~150 min, then declined over the following 2.5 h. POA PGE2 followed a concurrent course. Prazosin pretreatment eliminated the first Tc rise, but not the second; PGE2 rose normally. Yohimbine pretreatment did not affect the first Tc rise, which continued unchanged for 6 h; the second rise, however, was absent and PGE2 levels did not increase. SC-560 and acetaminophen did not alter the LPS-induced PGE2 and Tc rises; MK-0663 prevented both the late PGE2 and Tc rises. These results confirm that POA NE is pivotal in the development of LPS fever.
This article has been cited by other articles:
![]() |
J. A. Rathner, C. J. Madden, and S. F. Morrison Central pathway for spontaneous and prostaglandin E2-evoked cutaneous vasoconstriction Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2008; 295(1): R343 - R354. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |